Clearmind Medicine Inc. (CMND)

NASDAQ: CMND · IEX Real-Time Price · USD

1.640

-0.070 (-4.09%)

At close: Jul 19, 2024, 4:00 PM

1.630

-0.010 (-0.61%)

Pre-market: Jul 22, 2024, 7:34 AM EDT

Clearmind Medicine Income Statement

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Year Ending	TTM	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Selling, General & Admin	4.31	4.76	3.17	2.22	0.23
Research & Development	1.19	1.54	3.08	0.47	0
Operating Expenses	5.5	6.3	6.25	2.69	0.23
Operating Income	-5.5	-6.3	-6.25	-2.69	-0.23
Interest Expense / Income	-0.02	0	0	0	0
Other Expense / Income	1.2	2.3	0.61	0.03	0.18
Pretax Income	-6.68	-8.6	-6.87	-2.73	-0.41
Income Tax	0.24	0.02	0.03	0	0
Net Income	-6.92	-8.62	-6.89	-2.73	-0.41
Shares Outstanding (Basic)	3	0	0	0	0
Shares Outstanding (Diluted)	3	0	0	0	0
Shares Change	2504.47%	367.25%	40.19%	70.50%	-
EPS (Basic)	-14.96	-42.58	-159.11	-88.16	-22.80
EPS (Diluted)	-14.96	-42.58	-159.11	-88.16	-22.80
Free Cash Flow	-4.78	-6.3	-3.73	-2.1	-0.27
Free Cash Flow Per Share	-1.47	-31.12	-86.08	-67.98	-15.14
EBITDA	-6.66	-8.55	-6.78	-2.72	-0.41
Depreciation & Amortization	0.05	0.06	0.08	0	0
EBIT	-6.7	-8.6	-6.87	-2.73	-0.41

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).